Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p.
about
Novel biomarkers for pulmonary arterial hypertensionEpigenetic modulation as a therapeutic approach for pulmonary arterial hypertensionHigh-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung DiseaseRole of oxidized lipids in pulmonary arterial hypertensionPulmonary Hypertension in Children.The first annual Drug Discovery and Development Symposium for Pulmonary Hypertension.LimiTT: link miRNAs to targets.Update in Pulmonary Vascular Diseases 2014.Mechanisms and therapeutic potential of microRNAs in hypertension.Comprehensive Echocardiographic Assessment of the Right Ventricle in Murine Models.Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).Discerning functional hierarchies of microRNAs in pulmonary hypertension.Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy.Anti-apoptosis Endothelial Cell-secreted MicroRNA-195-5P promotes Pulmonary Arterial Smooth Muscle cell proliferation and migration in Pulmonary Arterial Hypertension.High-density lipoprotein mimetics: promises and challenges.microRNA and Pulmonary Hypertension.Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.Regulatory mechanisms in arterial hypertension: role of microRNA in pathophysiology and therapy.Advances in treatment of pulmonary arterial hypertension: patent review.Critical effects of epigenetic regulation in pulmonary arterial hypertension.Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension.High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1.MicroRNAs in right ventricular remodelling.Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension.Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.Downregulation of microRNA-193-3p inhibits the progression of intrahepatic cholangiocarcinoma cells by upregulating TGFBR3.Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer
P2860
Q26738666-E220C79E-713F-4DD9-AB28-DA3EA4B1AF29Q26801345-3C745CCE-A47C-4D4B-B51A-C4168523DCCBQ28075541-0484D76B-15F5-48A4-B4CF-13F9C2E79CB3Q28078566-9E9BC127-28CE-492A-9FF7-ADF62553BD2FQ30248871-B933C178-A26B-45FE-950B-41FD5CABF76FQ34782521-B1F6AE8A-B746-4A1B-B22E-1A3A1987EE38Q36015196-094C4088-95F9-4F24-97A9-D47D037E3B2EQ36128639-DC06B5A1-F13C-4B91-810B-9A7D8EB5928EQ36173562-FCAE01AF-7D14-4240-B994-CC0DFC8716F8Q37310286-3D6CDB90-3F3B-4623-9AE6-8541BA53512AQ37555447-27CE7839-A510-41E9-AF90-085A9FF25A3AQ37677437-A732CF04-EC0B-4C03-BB79-2DDE232B6C06Q37706691-3CA47366-BD3C-4547-84E1-69ED9C1CD77DQ37713722-B642A75F-3108-49AD-8501-873420EA5723Q38598171-B3FB4510-15C9-46FA-9AE4-F4865F5CAA39Q38650575-AED5C7AA-6450-4BD4-9F05-6E01B9976D31Q38668258-3420718D-1B21-4497-BE1D-0FA007537671Q38807248-3AF369D7-A189-4896-894F-E954A1BBF52BQ38833827-EECB3DEB-CB8F-489A-AC14-9ADC62028CA8Q39206788-44CEC146-E7EF-4A08-BDE0-0977BE36483AQ39345470-660E0DB7-4F15-435C-ACD2-236226D643AEQ40178749-42A42CFB-0F2F-424F-8414-C5633C15B862Q46047625-CD9E9648-C18F-42F9-A480-B7A11131DD6CQ48005120-A7002E38-B38E-4F1D-B22F-7A8E8C1122DBQ49312062-B8E10ADB-D64B-4C72-8B0E-614E7644452FQ49582789-BA840E3A-34D1-4CEF-A56C-C9C3EBAC0DF5Q49679377-562F46DC-1143-4952-A43C-D257F76E00C5Q52332818-D394421C-CB41-4198-8252-30E2B290BCDBQ55001904-CD006C1B-8C1E-4AE6-80D6-166E9A3F9BAAQ55208116-A81D14B7-8B1F-4AC8-8EEB-A00D6E3FC984Q58565322-AF1AF4BD-21C7-458A-A399-3B37B2F7FC0F
P2860
Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Apolipoprotein A-I mimetic pep ...... n by inducing microRNA-193-3p.
@en
Apolipoprotein A-I mimetic pep ...... n by inducing microRNA-193-3p.
@nl
type
label
Apolipoprotein A-I mimetic pep ...... n by inducing microRNA-193-3p.
@en
Apolipoprotein A-I mimetic pep ...... n by inducing microRNA-193-3p.
@nl
prefLabel
Apolipoprotein A-I mimetic pep ...... n by inducing microRNA-193-3p.
@en
Apolipoprotein A-I mimetic pep ...... n by inducing microRNA-193-3p.
@nl
P2093
P2860
P1433
P1476
Apolipoprotein A-I mimetic pep ...... n by inducing microRNA-193-3p.
@en
P2093
Alan M Fogelman
Andrea Iorga
David Meriwether
David Ross
Denise Mai
Francois Potus
Gabriel Wong
Kaveh Navab
Mansoureh Eghbali
Mohamad Navab
P2860
P304
P356
10.1161/CIRCULATIONAHA.114.007405
P407
P577
2014-06-24T00:00:00Z